|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 19.94 CNY | -0.20% |
|
-4.18% | +1.99% |
| 04-26 | Sansure Biotech Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
| 02-29 | Sansure Biotech's 2023 Profit Drops 81% as Revenue Slumps 84% | MT |
Sansure Biotech Inc. (SHSE:688289) announces a share repurchase program. Under the program, the company will repurchase up to CNY 120 million worth of shares. The shares will be repurchased at a price of not more than CNY 60 per share.
The shares purchased will be used for the company's equity incentive plan and employee stock ownership plans. The shares repurchased will be cancelled. The program will be valid for 12 months.
| 1st Jan change | Capi. | |
|---|---|---|
| +1.99% | 1.58B | |
| -4.47% | 12.33B | |
| -4.35% | 8.14B | |
| +8.86% | 5.89B | |
| +30.81% | 5.62B | |
| -7.42% | 4.24B | |
| -54.27% | 3.06B | |
| +14.44% | 2.76B | |
| -1.75% | 2.41B | |
| +28.53% | 2.23B |
SANSURE BIOTECH INC. 
